Insulin is a crucial lifeline for millions of people worldwide who manage diabetes. Insulin delivery systems are essential for the care and management of diabetes patients. BCC Research has classified these systems into four categories: syringes, insulin pens, insulin pumps, and smart pens. Our latest report on insulin drug and delivery technologies shows that traditional syringes and insulin pumps are being replaced by reusable and disposable insulin pens. This is because insulin pens provide greater dosage accuracy, ease of use, and portability.
The global market for emerging insulin drug and delivery technologies is expected to grow at a compound annual growth rate (CAGR) of 9.8% to reach over $88.9 billion by the end of 2028. BCC analysts predict a strong future for insulin drug delivery systems in the adoption and development of smart devices, as discussed in our latest report: Global Markets for Emerging Insulin Drug and Delivery Technologies.